Conference Reports for NATAP

Back

DDW Liver Conference   San Francisco, May 19-22, 2002     Review of Oral Presentations and Posters presented at DDW May 19-20 Written by Andrew Talal, MD, NY Hospital-Cornell Medical College, Dept of GI & Hepatology - (7/11/02)   Interferon alfa-2b plus Ribavirin for HCV-infected Patients with Normal ALT - (5/28/02)   IMPACT OF HIGH SERUM GLUCOSE ON LIVER FIBROSIS IN CHRONIC HEPATITIS C - (5/24/02)   HCV/HIV Coinfection at DDW Liver Conference - (5/24/02)   Fatigue, HCV/HIV Coinfection, Transmission, Disease Progression & Interferon Written by David Bernstein, MD, Chief of Hepatology at North Shore Hospital, Manhasset, NY - (5/23/02)   HCV /HIV Nonresponders Experience Improved Disease Progression - (5/23/02)   PEGINTERFERON ALPHA-2A ALONE OR IN COMBINATION WITH RIBAVIRIN ENHANCES RESTORATION OF THE HCV SPECIFIC T CELL RESPONSES IN PATIENTS WITH CHRONIC HEPATITIS C - (5/23/02)   BONE LOSS in HCV - (5/23/02)   HEPATITIS C - TRANSMISSION BY TOOTHBRUSHES: A MYTH OR A REAL POSSIBILITY? - (5/23/02)   Key Selected Highlights From Day One Hepatitis C Oral Presentations - (5/21/02)   Pegylated Interferon (PegIntron) and Ribavirin for Hep C Patients who were Previous Nonresponders - (5/21/02)   Prediction of Early Virologic Response to Pegasys plus Ribavirin in Patients with Genotype 1: can 24 hour viral load response predict 72 week outcome - (5/21/02)   PegIntron and Ribavirin in African-Americans and Caucasians; preliminary report - (5/21/02)   HCV Therapy in Methadone Maintenance - (5/21/02)